BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Liver
,
Autoimmunity
,
Cisplatin
,
rs7903146
,
IL1A
,
Metabolism of xenobiotics
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
neprilysin
(gene)
NextBio Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Bacterial infectious disease
Staphylococcal infectious disease
Deficiency state
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Ethidium Bromide
royal jelly
Dichlorvos
Ultraviolet Rays
Mercuric Chloride
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
alg-1
bar-1
crh-1
let-60
lin-54
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
C. elegans L1 larvae exposed to EtBr and/or serial UVC radiation
C. elegans responses to DNA damage and starvation in xpa-1, daf-2 and daf-16 mutant L1 larvae
Downstream targets of let-60 Ras in Caenorhabditis elegans
C. elegans with gas-1(fc21) mutation treated with fenofibrate, niacin, resveratrol, or rosiglitazone
C. elegans pmk-1, ogt-1 or oga-1 mutant larvae, exposed to pathogenic S. aureus or P. aeruginosa
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for neprilysin
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition
Influences of Angiotensin-neprilysin Inhibition on Sympathetic Activity in Heart Failure
The Effect of Angiotensin Receptor-Neprilysin Inhibition on Cardiac Fibrosis in Patients With HFpEF
The Effect of Neprilysin (LCZ696) on Exercise Tolerance in Patients With Heart Failure
Effect of Angiotensin-Neprilysin Inhibition (ARNI) on Prognosis of Chronic Heart Failure
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ